Impact of the COVID-19 crisis on imaging in oncological trials

Deroose, Christophe M; Lecouvet, Frédéric E; Collette, Laurence; Oprea-Lager, Daniela E; Kunz, Wolfgang G; Bidaut, Luc; Verhoeff, Joost J C; Caramella, Caroline; Lopci, Egesta; Tombal, Bertrand; de Geus-Oei, Lioe-Fee; Fournier, Laure; Smits, Marion; deSouza, Nandita M

doi:https://doi.org/10.1007/s00259-020-04910-y

Impact of the COVID-19 crisis on imaging in oncological trials

DSpace/Manakin Repository

Impact of the COVID-19 crisis on imaging in oncological trials

Deroose, Christophe M; Lecouvet, Frédéric E; Collette, Laurence; Oprea-Lager, Daniela E; Kunz, Wolfgang G; Bidaut, Luc; Verhoeff, Joost J C; Caramella, Caroline; Lopci, Egesta; Tombal, Bertrand; de Geus-Oei, Lioe-Fee; Fournier, Laure; Smits, Marion; deSouza, Nandita M

(2020) European Journal of Nuclear Medicine and Molecular Imaging, volume 47, issue 9, pp. 2054 - 2058

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Radiology Nuclear Medicine and imaging, Editorial

DOI: https://doi.org/10.1007/s00259-020-04910-y

ISSN: 1619-7070

Publisher: Springer-Verlag

Note: Funding Information: This publication was supported by a donation from “Kom op tegen Kanker” from Belgium. Christophe M. Deroose is a Senior Clinical Investigator at Research Foundation—Flanders (FWO). No writing assistance was obtained for this manuscript.

(Peer reviewed)